Journal
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
Volume 94, Issue -, Pages 302-320Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neubiorev.2018.07.006
Keywords
Endocannabinoids; Posttraumatic stress disorder; Sex differences; Translational medical research; Oestrogens; Cannabis; Psychiatric disorders; Traumatic stress; Cannabinoids
Categories
Funding
- NHMRC program [APP1073041]
Ask authors/readers for more resources
The endocannabinoid system is an increasingly recognised pharmacological target for treating stress and anxiety disorders, including post-traumatic stress disorder (PTSD). Recent preclinical developments have implicated the endocannabinoid system in stress responses, emotional memories and fear extinction, all critical to PTSD aetiology. However, preclinical research in endocannabinoid biology has neglected the influential role of sex hormone differences on PTSD symptomology, which is particularly important given that PTSD is twice as common in women as in men. In this review, we compile and consider the evidence that the endocannabinoid system is influenced by ovarian hormones, with application to stress disorders such as PTSD. It is clear that therapeutic modulation of the endocannabinoid system needs to be approached with awareness of ovarian hormonal influences, and knowledge of these influences may enhance treatment outcomes for female PTSD populations.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available